Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies.
Ontology highlight
ABSTRACT: This study aimed to estimate the rates of biopsy undersampling and progression for four prostate cancer (PCa) active surveillance (AS) cohorts within the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. We used a hidden Markov model (HMM) to estimate factors that define PCa dynamics for men on AS including biopsy under-sampling and progression that are implied by longitudinal data in four large cohorts included in the GAP3 database. The HMM was subsequently used as the basis for a simulation model to evaluate the biopsy strategies previously proposed for each of these cohorts. For the four AS cohorts, the estimated annual progression rate was between 6%-13%. The estimated probability of a biopsy successfully sampling undiagnosed non-favorable
SUBMITTER: Li W
PROVIDER: S-EPMC7774732 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA